Diagnosed with cancer and given “12 to 18 months to live,” Mike Milken took on the task of shaking up the prostate cancer research field. And by increasing venture funding, promoting collaboration, and going public, he did just that.
See More Remarkable Givers
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Permissions beyond the scope of this license are available in our Terms and Conditions.

Show Comments

More Articles To Read

Pay What It Takes 

Pay What It Takes 

Remarkable Givers Video